Postoperative immune-related adverse events after conversion surgery following induction immune checkpoint inhibitor-combined chemotherapy in patients with unresectable esophagogastric junction carcinoma: a report of two cases
The risk of irAEs should always be considered in patients receiving ICIs, even after conversion surgery. This condition should be differentiated from complications of esophagectomy and managed promptly.
Authors
- Yoshiaki Shoji (ORCID: https://orcid.org/0000-0003-3074-1398)
- Kohei Kanamori
- Mika Ogimi
- Kohei Tajima
- Kazuo Koyanagi
- Akihito Kazuno
- Masaki Mori
- Miho Yamamoto
- Takayuki Nishi
- Yamato Ninomiya
- Rie Nakashima
Institutions
- Tokai University (JP)
Publication Details
- Journal
- Journal of Cardiothoracic Surgery
- Published
- 2025-12-31
- DOI
- https://doi.org/10.1186/s13019-025-03777-0
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.01